Real Estate

National Health Investors Executive Compensation (FY25)

NHI · Murfreesboro, TN · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
D. Eric Mendelsohn
Latest say-on-pay support
=
May 27, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in Real Estate, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on National Health Investors

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Data as of October 22, 2026Latest filing (8-K): May 29, 2026
13 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
National Health Investors brief$1,500Get the executive brief
Velarion Member, one year
301 figures on this page: 290 cited to the filing that reported them, 11 calculated from figures it prints. See the citations

More on National Health Investors

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — D. Eric Mendelsohn: $2,246,596 → $3,652,795 (62.6% higher)
Say-on-pay support: 95.7% → 95.8% (0.1 points higher)
CEO pay ratio: 10:1 → 18:1 (80.0% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is National Health Investors' chief executive and what were they paid?
D. Eric Mendelsohn was paid $3,652,795 in total compensation as President and CEO for fiscal 2025. Mendelsohn's total moved 62.6% higher from the $2,246,596 reported for fiscal 2024.
What was National Health Investors' say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 95.8% of votes cast for or against in favor at the meeting held May 27, 2026.
Which companies are in National Health Investors' peer group?
The disclosed peer group includes American Healthcare REIT, Inc., Broadstone Net Lease, Inc, CareTrust REIT, Inc., Chiron Real Estate Inc. and Community Healthcare Trust Incorporated, among others.
What is National Health Investors' chief executive pay ratio?
The company reported a chief executive pay ratio of 18:1 for fiscal 2025, against median employee compensation of $206,619.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
D. Eric Mendelsohn
President and Chief Executive Officer
◇◇—◇——◇◇
John Spaid
Chief Financial Officer, Treasurer, and Executive Vice President of Finance
◇◇—◇——◇◇
Kristin Gaines
Chief Credit Officer
◇◇—◇——◇◇
Kevin Pascoe
Chief Investment Officer
◇◇—◇——◇◇
David Travis
Chief Accounting Officer
◇◇—◇——◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
D. Eric Mendelsohn
President and Chief Executive Officer
◇—◇◇◇—◇◇
John Spaid
Executive Vice President of Finance, Chief Financial Officer and Treasurer
◇◇◇◇◇—◇◇
Kevin Pascoe
Executive Vice President of Investments and Chief Investment Officer
◇—◇◇◇—◇◇
Kristin Gaines
Senior Vice President and Chief Transaction Officer
◇◇◇◇◇—◇◇
David Travis
Senior Vice President and Chief Accounting Officer
◇◇◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
D. Eric Mendelsohn
CEO and President
◇—◇◇◇—◇◇
John Spaid
Chief Financial Officer
◇—◇◇◇—◇◇
Kevin Pascoe
Chief Investment Officer
◇—◇◇◇—◇◇
Kristin Gaines
Chief Transaction Officer
◇—◇◇◇—◇◇
David Travis
Chief Accounting Officer
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
D. Eric Mendelsohn
President and CEO
◇—◇◇◇—◇◇
John Spaid
Executive Vice President of Finance, Chief Financial Officer and Treasurer
◇—◇◇◇—◇◇
Kevin Pascoe
Executive Vice President of Investments and Chief Investment Officer
◇—◇◇◇—◇◇
David Travis
Senior Vice President and Chief Accounting Officer
◇—◇◇◇—◇◇
Kristin Gaines
Senior Vice President and Chief Transaction Officer
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
D. Eric MendelsohnRSU◇——◇——◇
D. Eric MendelsohnOPTION◇——◇—◇◇
David L. TravisRSU◇——◇——◇
David L. TravisOPTION◇——◇—◇◇
John L. SpaidRSU◇——◇——◇
John L. SpaidOPTION◇——◇—◇◇
Kevin C. PascoeRSU◇——◇——◇
Kevin C. PascoeOPTION◇——◇—◇◇
Kristin S. GainesOPTION◇——◇—◇◇
Kristin S. GainesRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Kevin PascoeRSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
Kristin GainesOption◇—◇—
RSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
David TravisOption◇—◇—
Option◇—◇—
Option◇—◇—
RSU◇◇——
Option◇—◇—
D. MendelsohnOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
RSU◇◇——
John SpaidOption◇—◇—
Option◇—◇—
Option◇—◇—
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
D. Eric Mendelsohn
President and CEO · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance base◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Non-compete period◇
Non-solicit period◇
David Travis
Senior Vice President and Chief Accounting Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Non-compete period◇
Non-solicit period◇
Kevin Pascoe
Executive Vice President of Investments and Chief Investment Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Non-compete period◇
Non-solicit period◇
Kristin Gaines
Senior Vice President and Chief Transaction Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Change-in-control multiple◇
Benefits continuation on change in control◇
Non-compete period◇
Non-solicit period◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Robert A. McCabe, Jr
Board chair
◇—◇———◇
Candice W. Todd
◇—◇———◇
Tracy M.J. Colden
◇—◇———◇
James R. Jobe
◇—◇———◇
Charlotte A. Swafford
◇—◇———◇
Robert G. Adams
◇—◇———◇
Robert W. Chapin, Jr
◇—◇———◇
Robert T. Webb
◇—◇———◇
Lilly H. Donohue and D. Eric Mendelsohn served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance member◇
Board meeting fee◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • American Healthcare REIT, Inc. AHR
  • Broadstone Net Lease, Inc BNL
  • CareTrust REIT, Inc. CTRE
  • Chiron Real Estate Inc. XRN
  • Community Healthcare Trust Incorporated CHCT
  • Easterly Government Properties, Inc. DEA
  • EPR EPR
  • Healthcare Realty Trust Incorporated HR
  • LTC Properties, Inc. LTC
  • LXP Industrial Trust LXP
  • National Healthcare Properties, Inc. NHPAP
  • NETSTREIT Corp NTST
  • Sabra Health Care REIT, Inc. SBRA
  • Sila Realty Trust, Inc. SILA
  • Terreno Realty Corporation TRNO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 27, 2026=◇◇◇
2024May 21, 2025=◇◇◇
2023May 22, 2024=◇◇◇
2022May 5, 2023=◇◇◇
2021May 6, 2022=◇◇◇
2020May 4, 2021=◇◇◇
2019May 6, 2020=◇◇◇
2018May 3, 2019=◇◇◇
2017May 4, 2018=◇◇◇
2016May 8, 2017=◇◇◇
2015May 5, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- D. Eric Mendelsohn (President and CEO), FY2025 total compensation $3,652,795 (base salary $700,000) [exec_comp, SEC accession 0000877860-26-000098, filed 2026-04-03]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when National Health Investors files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact National Health Investors disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where National Health Investors sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether National Health Investors' disclosed peer group is defensible, who names National Health Investors back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
301 figures on this page: 290 cited to the filing that reported them, 11 calculated from figures it prints.
290 cited to the filing
11 calculated from the filing

Documents cited

  1. 0000877860-26-000149
  2. 0000877860-26-000098
    2025 Director Compensation · 2025 Outstanding Equity Awards at Fiscal Year-End · 2025 Summary Compensation Table · CEO Pay Ratio · and 4 more sections
  3. 0000877860-25-000111
  4. 0000877860-25-000063
  5. 0000877860-24-000054
  6. 0000877860-23-000064
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0000877860-22-000044
    Say-on-Pay Proposal
  8. 0000877860-21-000034
    Say-on-Pay Proposal
  9. 0000877860-20-000072
  10. 0000877860-19-000030
  11. 0000877860-18-000043
  12. 0000877860-17-000054
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0000877860-16-000132
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “National Health Investors executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/NHI (accessed 2026).
Short form: data: Velarion

The paid brief for National Health Investors

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about National Health Investors and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Real Estate rankings

Peers National Health Investors discloses

The companies named in NHI's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy